PANTALEO, PIETRO

PANTALEO, PIETRO  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.015 secondi).
Titolo Data di pubblicazione Autore(i) File
An uncommon clinical presentation of retroperitoneal non-Hodgkin lymphoma successfully treated with chemotherapy: a case report 2005 C. FULIGNATI; P. PANTALEO; G. CIPRIANI; M. TURRINI; R. NICASTRO; R. MAZZANTI; B. NERI
CARDIOVASCULAR EFFECTS OF CANRENONE IN PRE-ASCITIC CIRRHOSIS. 2002 Pietro Pantaleo; Giorgio La Villa; Giuseppe Barletta; Roberto Giulio Romanelli; Riccarda Del Bene; Giacomo Laffi; Paolo Gentilini.
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 2002 G La Villa; G Barletta; RG Romanelli; G Laffi; R Del Bene; F Vizzutti; P Pantaleo; V Mazzocchi; P Gentilini
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 2001 P. Caini; A. Mazzocca; C. Cordella; C. Giannini; P. Pantaleo; R.G. Romanelli; M. E. Marrocchi; G. Laffi; P. Gentilini; A.L. Zignego.
Differential expression proteomics of human colon cancer 2006 R.Mazzanti;M.Solazzo;O.FANTAPPIE';S.Elfering;P.Pantaleo;P.Bechi;F.Cianchi;A.Ettl;C.Giulivi
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. 2004 Pantaleo P;Marra F;Vizzutti F;Spadoni S;Ciabattoni G;Galli C;La Villa G;Gentilini P;Laffi G
Farnesyltransferase inhibitor ABT-100 is a potent liver cancer chemopreventive agent 2005 V. CARLONI; VIZZUTTI F; PANTALEO P
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 2001 G. La Villa; G. Barletta; P. Pantaleo; R. Del Bene; F. Vizzutti; S. Vecchiarino; E. Masini; F. Perfetto; R. Tarquini; P. Gentilini; G. Laffi
High prevalence of hypertension in O positive ABO subjects: a NMR spectroscopy study 2014 M. Biagioli;P. Pantaleo;L. Tenori;B. Alterini;C. Luchinat;G. Castelli;G. M. Brizzi;D. Duranti;X. Hu;G. F. Gensini
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 2006 Romanelli RG; La Villa G; Barletta G; Vizzutti F; Lanini F; Arena U; Boddi V; Tarquini R; Pantaleo P; Gentilini P; Laffi G.
Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study. 2006 NERI B; VANNOZZI L; FULIGNATI C; PANTALEO P; PANTALONE D; PAOLETTI C; PERFETTO F; TURRINI M; R. MAZZANTI
Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure 2014 Padeletti L; Modesti PA; Cartei S; Checchi L; Ricciardi G; Pieragnolia P; Sacchi S; Padeletti M; Alterini B; Pantaleo P; Hu X; Tenori L; Luchinat C
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: A phase II study 2007 Neri, B.; Pantaleo, P.; Giommoni, E.; Grifoni, R.; Paoletti, C.; Rotella, V.; Pantalone, D.; Taddei, A.; Mercatelli, A.; Tonelli, P.
The metabolomic features of stable heart failure. A prospective study, 12 months follow-up 2014 M. Biagioli;P. Pantaleo;L. Tenori;B. Alterini;C. Luchinat;G. Castelli;G. M. Brizzi;D. Duranti;X. Hu;G. F. Gensini
Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: a pilot study. 2004 R.Mazzanti;AL.Giallombardo;E.Mini;S.Nobili;B.Neri;U.Arena; P.Pantaleo;V.Fabbroni;M.Ghilardi;R.Gattai;L.Bandettini
Vitamin E protects DNA from oxidative damage in human hepatocellular carcinoma cell lines 2004 O. FANTAPPIE'; M. Lodovici; P. Fabrizio; S. Marchetti; V. Fabbroni; M. Solazzo; N. Lasagna;P. Pantaleo; R. Mazzanti
Weekly administration of docetaxel and epirubicin as first-line treatment for hormone refractory prostate cancer 2009 B. Neri;E.Molinara;P.Pantaleo;S.Rangan;A.Crisci; A.Della Melina;A.Raugei;D.Villari;G.Nicita